A detailed history of Gabelli Funds LLC transactions in Danaher Corp stock. As of the latest transaction made, Gabelli Funds LLC holds 19,725 shares of DHR stock, worth $4.55 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
19,725
Previous 19,725 -0.0%
Holding current value
$4.55 Million
Previous $4.93 Million 11.26%
% of portfolio
0.04%
Previous 0.04%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$235.51 - $267.98 $390,946 - $444,846
-1,660 Reduced 7.76%
19,725 $4.93 Million
Q1 2024

May 14, 2024

SELL
$224.58 - $256.19 $119,027 - $135,780
-530 Reduced 2.42%
21,385 $5.34 Million
Q4 2023

Feb 13, 2024

SELL
$185.1 - $233.13 $6.74 Million - $8.49 Million
-36,399 Reduced 62.42%
21,915 $5.07 Million
Q3 2023

Nov 08, 2023

SELL
$233.08 - $265.59 $6.77 Million - $7.71 Million
-29,046 Reduced 33.25%
58,314 $14.5 Million
Q2 2023

Aug 10, 2023

SELL
$224.99 - $256.14 $2.3 Million - $2.62 Million
-10,220 Reduced 10.47%
87,360 $21 Million
Q1 2023

May 12, 2023

SELL
$239.75 - $277.0 $3.54 Million - $4.09 Million
-14,750 Reduced 13.13%
97,580 $24.6 Million
Q4 2022

Feb 13, 2023

SELL
$241.42 - $282.29 $4.79 Million - $5.6 Million
-19,850 Reduced 15.02%
112,330 $29.8 Million
Q3 2022

Nov 10, 2022

SELL
$247.06 - $1507.4 $260,154 - $1.59 Million
-1,053 Reduced 0.79%
132,180 $34.1 Million
Q2 2022

Aug 12, 2022

SELL
$237.11 - $299.66 $2.82 Million - $3.57 Million
-11,898 Reduced 8.2%
133,233 $33.8 Million
Q1 2022

May 13, 2022

BUY
$257.27 - $315.76 $166,710 - $204,612
648 Added 0.45%
145,131 $42.6 Million
Q4 2021

Feb 11, 2022

BUY
$292.08 - $329.01 $10.9 Million - $12.3 Million
37,263 Added 34.75%
144,483 $47.5 Million
Q3 2021

Nov 12, 2021

SELL
$272.21 - $332.43 $1.86 Million - $2.27 Million
-6,833 Reduced 5.99%
107,220 $32.6 Million
Q2 2021

Aug 13, 2021

BUY
$225.08 - $271.69 $473,793 - $571,907
2,105 Added 1.88%
114,053 $30.6 Million
Q1 2021

May 14, 2021

SELL
$212.38 - $245.9 $3.45 Million - $4 Million
-16,262 Reduced 12.68%
111,948 $25.2 Million
Q4 2020

Feb 05, 2021

SELL
$212.5 - $245.46 $223,125 - $257,733
-1,050 Reduced 0.81%
128,210 $28.5 Million
Q2 2020

Aug 13, 2020

BUY
$128.7 - $176.83 $3.31 Million - $4.54 Million
25,700 Added 24.82%
129,260 $22.9 Million
Q1 2020

May 14, 2020

SELL
$121.39 - $169.05 $501,947 - $699,021
-4,135 Reduced 3.84%
103,560 $14.3 Million
Q4 2019

Feb 14, 2020

BUY
$133.47 - $153.48 $2.36 Million - $2.72 Million
17,690 Added 19.65%
107,695 $16.5 Million
Q2 2019

Aug 02, 2019

SELL
$124.88 - $143.73 $43,208 - $49,730
-346 Reduced 0.38%
90,005 $12.9 Million
Q1 2019

May 02, 2019

SELL
$97.62 - $132.29 $7,321 - $9,921
-75 Reduced 0.08%
90,351 $11.9 Million
Q4 2018

Jan 30, 2019

BUY
$94.85 - $109.54 $2,371 - $2,738
25 Added 0.03%
90,426 $9.33 Million
Q3 2018

Nov 02, 2018

BUY
$98.13 - $108.9 $181,540 - $201,465
1,850 Added 2.09%
90,401 $9.82 Million
Q2 2018

Aug 10, 2018

BUY
$96.1 - $103.24 $1.18 Million - $1.27 Million
12,300 Added 16.13%
88,551 $8.74 Million
Q3 2017

Nov 01, 2017

BUY
$79.29 - $88.45 $6.05 Million - $6.74 Million
76,251
76,251 $6.54 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $168B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Gabelli Funds LLC Portfolio

Follow Gabelli Funds LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gabelli Funds LLC with notifications on news.